Publication | Closed Access

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Tumor BiologyMedicineImmunologyClinical RelevancePathologyTumor CellsImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyFront-line TreatmentLung CancerCancer Research